Lv5
1358 积分 2024-07-13 加入
Fragment-based drug design facilitates selective kinase inhibitor discovery
10天前
已完结
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
10天前
已完结
Substrate recognition and cleavage mechanism of the monkeypox protease, Core protease
11天前
已完结
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
13天前
已完结
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors
14天前
已完结
A phase 1/2 study of the TORC1/2 inhibitor onatasertib combined with toripalimab in patients with advanced solid tumors: Cervical cancer cohort
14天前
已完结
HER2-targeted therapies beyond breast cancer — an update
14天前
已完结
Tumour-agnostic kinase inhibitors
14天前
已完结
Long-term 4-nonylphenol exposure drives cervical cell malignancy through MAPK-mediated ferroptosis inhibition
14天前
已完结
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
14天前
已完结
皖公网安备34019202002308
